Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 6,120 shares at $35.15 ($216K) on 2015-01-02, disclosed to the SEC on 2015-01-05.
Scheduled sale ($216k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.15 | 3,000 | $105K | 48.7% |
| 2 | $35.59 | 3,120 | $111K | 51.3% |
| Total | $35.37 avg | 6,120 | $216K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |